Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Farxiga (dapagliflozin) for Glycemic Control in Children Aged 10 Years and Older with Type-2 Diabetes

12 June 2024 – AstraZeneca’s Farxiga (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycaemic control...

FDA Approves Kevzara (sarilumab) for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)

  TARRYTOWN, N.Y. and CAMBRIDGE, MA, June 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)...

FDA Approves Almirall’s Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on Expanded Area of Face or Scalp

Almirall, a global pharmaceutical company dedicated to medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has approved...

FDA Approves Expanded Age Indication for GSK’s Arexvy, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine,...

FDA Grants Accelerated Approval to Iqirvo (elafibranor) for the Treatment of Primary Biliary Cholangitis

PARIS, FRANCE, 10 June 2024: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated...

International Travel: Don't Forget Your Child's Vaccinations

Exploring Europe, taking an African safari, going on a trip to the tropics: In many cases, vaccines are needed for travel, and that's doubly true for children....

Protect Your Eyes From Summer's Dangers

Summertime is primetime for the great outdoors, but that can mean new hazards for your eyes, one expert warned. Simple steps can help cut the risk, said...

Positive Family Relationships May Protect Against Pain in Older Adults

Family support may protect against pain incidence and persistence among aging African Americans, according to a study published online May 20 in the Journals...

Past-Year Pap Testing Rates Were Lower in 2022 Than 2019

Past-year Papanicolaou testing rates were lower in 2022 than in 2019, overall, and lower rates were seen in rural versus urban women, according to a study...

FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular Dystrophy

The U.S. Food and Drug Administration has approved the first generic version of Emflaza (deflazacort) oral suspension for Duchenne muscular dystrophy (DMD).Deflazacort...

'Good Days and Bad:' Catherine, Princess of Wales, Gives Cancer Update

Catherine, Princess of Wales, has released the first update on her cancer journey since announcing her diagnosis in late March.In a message posted to her...

Midlife Inflammation Tied to Slowing of Gait Speed in Later Life

Inflammation in midlife may contribute to clinically meaningful late-life slowing of gait speed, according to a study published online June 12 in the Journal...

Loaded, Unlocked Guns Common in American Homes, Study Finds

In half of American homes containing a loaded gun, that gun is kept unsecured and ready for potential use, often with children in the home, new research...

New CIMZIA data for women living with chronic rheumatic diseases throughout pregnancy, and for people living with RA and high rheumatoid factor levels

ATLANTA, June 13, 2024. UCB, a global biopharmaceutical company, will present results from three studies for CIMZIA (certolizumab pegol), a PEGylated fragment...

Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity

CRANBURY, N.J., June 12, 2024. Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate...

Male Enhancement Supplements Recalled

Integrity Products , St Louis MO is voluntarily recalling tainted lot (HGW221116) within expiry of the Ram It & To The Moon capsules to the consumer...

Taking a GLP-1 Medicine? Here's What Experts Say You Should Eat

Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements for good health, even if they’re eating less. A...

New Indication for Motpoly XR (Lacosamide Extended-Release) Capsules for Primary Generalized Tonic-Clonic Seizures (Adjunctive Treatment)

Today, the U.S. Food and Drug Administration (FDA) granted Aucta Pharmaceuticals a prior approval supplemental new drug application for the use of Motpoly...

Read more news...

Recently Added

Recently added consumer and prescribing information: Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Iqirvo Iqirvo (elafibranor) is a dual peroxisome-activated receptor (PPAR) alpha/delta (α,δ) agonist used for the treatment of patients with p...
  • Rytelo Rytelo (imetelstat) is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low- to intermediate-1...
  • mRESVIA mRESVIA is a modified RNA vaccine that may protect adults aged 60 years and older from lower respiratory tract disease caused by an RSV infection.

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development